Emerging cardiometabolic complications of androgen deprivation therapy

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease

(2009) A. M. Traish et al.   JOURNAL OF ANDROLOGY

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer

(2008) Daniel A. Galvão et al.   BJU INTERNATIONAL

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer

(2008) Matthew R. Smith et al.   CANCER

Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02

(2008) Jason A. Efstathiou et al.   EUROPEAN UROLOGY

Changes in Muscle Mass, Muscle Strength, and Power but Not Physical Function Are Related to Testosterone Dose in Healthy Older Men

(2008) Thomas W. Storer et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer

(2008) Matthew R. Smith et al.   UROLOGY

Low Serum Testosterone and Mortality in Older Men

(2007) Gail A. Laughlin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM